James McNulty

James McNulty

Director of Finance/CFO chez INHIBITOR THERAPEUTICS, INC.

Fortune : 76 729 $ au 31/03/2024

73 ans
Health Technology
Commercial Services
Distribution Services

Profil

James A.
McNulty
is the founder of Pender, McNulty & Newkirk, which was founded in 1976.
Mr. McNulty is also the founder of McNulty & Co., McNulty, Garcia & Ortiz PA.
.
Mr. McNulty's current job(s) include being the Director-Tampa Bay Chapter at Financial Executives International since 2013, Director at Quantum Technology Sciences, Inc. since 2012, Member of The American Institute of Certified Public Accountants, Member of the Florida Institute of Certified Public Accountants, Chief Financial Officer, Secretary & Treasurer at Inhibitor Therapeutics, Inc. since 2022, and Chief Financial Officer at Repurposed Therapeutics, Inc.Mr. McNulty's former job(s) include being the Chief Executive Officer of MyMD Pharmaceuticals (Florida), Inc. from 2014 to 2020, Lead Independent Director of CV Sciences, Inc. from 2016 to 2020, Chief Financial Officer of Rock Creek Pharmaceuticals, Inc. from 1998 to 2000, Treasurer & Senior Vice President of BioDelivery Sciences International, Inc. from 2000 to 2014, Chief Financial Officer of BioVest International, Inc. from 2003 to 2007, Secretary & Treasurer of Accentia Biopharmaceuticals, Inc. from 2002 to 2013, Chief Operating & Financial Officer of American Prescription Providers, Inc. from 2000 to 2002, Chief Financial Officer of TEAMM Pharmaceuticals, Inc., Chief Financial Officer of RetinaPharma Technologies, Inc., Chief Financial Officer of Hopkins Capital Group, and Chief Executive & Financial Officer of Defender Pharmaceuticals, Inc. Mr. McNulty was also the Chief Financial Officer of MIRA Pharmaceuticals, Inc. from 2020 to 2023.
Mr. McNulty obtained an undergraduate degree from the University of South Florida in 1972.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
29/03/2024 1 096 135 ( 0,64% ) 76 729 $ 31/03/2024

Postes actifs de James McNulty

SociétésPosteDébut
INHIBITOR THERAPEUTICS, INC. Director of Finance/CFO 13/12/2022
Repurposed Therapeutics, Inc. Director of Finance/CFO -
Corporate Officer/Principal -
Director/Board Member 01/01/2012
Florida Institute of Certified Public Accountants Corporate Officer/Principal -
Corporate Officer/Principal -
Tous les postes actifs de James McNulty

Anciens postes connus de James McNulty

SociétésPosteFin
MIRA PHARMACEUTICALS, INC. Director of Finance/CFO 01/12/2023
CV SCIENCES, INC. Director/Board Member 27/07/2020
Chief Executive Officer 01/01/2020
░░░░░░░░░░░ ░░░░░░░░ ░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░ ░░ ░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de James McNulty

Formation de James McNulty

University of South Florida Undergraduate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de James McNulty

Relations

100 +

Relations au 1er degré

23

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées3
CV SCIENCES, INC.

Health Technology

INHIBITOR THERAPEUTICS, INC.

Health Technology

MIRA PHARMACEUTICALS, INC.

Health Technology

Entreprise privées19

Health Technology

Health Technology

Technology Services

Health Technology

Health Technology

Retail Trade

Commercial Services

Distribution Services

Commercial Services

Florida Institute of Certified Public Accountants

Distribution Services

Pender, McNulty & Newkirk

Commercial Services

McNulty, Garcia & Ortiz PA

Electronic Technology

Finance

Repurposed Therapeutics, Inc.

Health Technology

Defender Pharmaceuticals, Inc.

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. James McNulty